Zobrazeno 1 - 10
of 133
pro vyhledávání: '"Abhishek A. Solanki"'
Autor:
Supriya Mallick, Anjali V.R, Prashanth Giridhar, Rituraj Upadhyay, Byung-Kyu Kim, Amrish Sharma, Hagar Elghazawy, Thiraviyam Elumalai, Vinod Solipuram, Cheng En Hsieh, Courtney Hentz, Abhishek A. Solanki, Jing Li, Dennis Pai Chan, Emily Ness, Bhanu Prasad Venkatesulu, David R. Grosshans
Publikováno v:
South Asian Journal of Cancer, Vol 11, Iss 04, Pp 361-369 (2022)
Abstract Supriya Mallick Introduction Malignant gliomas are the most common primary malignant brain tumors and are typically treated with maximal safe surgical resection followed by chemoradiation. One of the unintended effects of radiation is depl
Externí odkaz:
https://doaj.org/article/1cd14184d99d472895aab458848d0ae4
Autor:
Amy Moreno, Abhishek A. Solanki, Tianlin Xu, Ruitao Lin, Jatinder Palta, Emily Daugherty, David Hong, Julian Hong, Sophia C. Kamran, Evangelia Katsoulakis, Kristy Brock, Mary Feng, Clifton Fuller, Charles Mayo, BDSC Prostate Cancer
Publikováno v:
Cancers, Vol 15, Iss 12, p 3121 (2023)
Background: Clinical data collection related to prostate cancer (PCa) care is often unstructured or heterogeneous among providers, resulting in a high risk for ambiguity in its meaning when sharing or analyzing data. Ontologies, which are shareable f
Externí odkaz:
https://doaj.org/article/ce8cb8cec5e34b189b5cd93fbbd6cb74
Autor:
Murat Surucu, PhD, Amishi Bajaj, MD, John C. Roeske, PhD, Alec M. Block, MD, Jennifer Price, CMD, William Small, Jr., MD, FACRO, FACR, FASTRO, Abhishek A. Solanki, MD, MS
Publikováno v:
Advances in Radiation Oncology, Vol 4, Iss 3, Pp 532-540 (2019)
Purpose: Our peer-review program previously consisted of weekly chart rounds performed before the end of the first week of treatment. In order to perform peer review before the start of treatment when possible, we implemented daily prospective contou
Externí odkaz:
https://doaj.org/article/c8ac8c7e889c4ce7bc701e43a6ec2f34
Autor:
Abhishek A. Solanki, Lindsay L. Puckett, Ksenija Kujundzic, Evangelia Katsoulakis, John Park, Rishabh Kapoor, Michael Hagan, Maria Kelly, Jatinder Palta, Leslie K. Ballas, John DeMarco, Karen E. Hoffman, Colleen A.F. Lawton, Jeff Michalski, Louis Potters, Michael Zelefsky, Randi Kudner, Samantha Dawes, Emily Wilson, Howard Sandler
Publikováno v:
Practical Radiation Oncology. 13:e149-e165
There are no agreed upon measures to comprehensively determine the quality of radiation oncology (RO) care delivered for prostate cancer. Consequently, it is difficult to assess the implementation of scientific advances and adherence to best practice
Autor:
BhanuPrasad, Venkatesulu, Prashanth, Giridhar, Lincoln, Pujari, Brian, Chou, Jae Han, Lee, Alec M, Block, Rituraj, Upadhyay, James S, Welsh, Matthew M, Harkenrider, Sunil, Krishnan, Vivek, Verma, Cheng, En Hsieh, Satyajit, Pradhan, William, Small, Abhishek A, Solanki
Publikováno v:
Radiotherapy and Oncology. 177:81-94
Radiation-related lymphopenia has been associated with suboptimal tumor control rates leading to inferior survival outcomes. To date, no standardized dose constraints are available to limit radiation dose to resident and circulating lymphocyte popula
Autor:
Mark T. Corkum, Mark K. Buyyounouski, Albert J. Chang, Hans T. Chung, Peter Chung, Brett W. Cox, Juanita M. Crook, Brian J. Davis, Steven J. Frank, Ivan Henriquez, Eric M. Horwitz, Peter Hoskin, I-Chow Hsu, Mira Keyes, Martin T. King, Marisa A. Kollmeier, Daniel J. Krauss, Andrzej M. Kukielka, Gerard Morton, Peter F. Orio, Bradley R. Pieters, Louis Potters, Peter J. Rossi, Timothy N. Showalter, Abhishek A. Solanki, Daniel Song, Ben Vanneste, Eric Vigneault, Piotr A. Wojcieszek, Michael J. Zelefsky, Mitchell Kamrava
Publikováno v:
Radiotherapy and oncology, 184:109672. Elsevier Ireland Ltd
Radiotherapy and Oncology, 184:109672. Elsevier Ireland Ltd
Radiotherapy and Oncology, 184:109672. Elsevier Ireland Ltd
Background and Purpose: Local recurrences after previous radiotherapy (RT) are increasingly being identified in biochemically recurrent prostate cancer. Salvage prostate brachytherapy (BT) is an effective and well tolerated treatment option. We sough
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae21e4a6756492ceff8636cf551050d8
https://pure.amc.nl/en/publications/salvage-prostate-brachytherapy-in-radiorecurrent-prostate-cancer(10a618af-3823-438d-acb1-38b682c83559).html
https://pure.amc.nl/en/publications/salvage-prostate-brachytherapy-in-radiorecurrent-prostate-cancer(10a618af-3823-438d-acb1-38b682c83559).html
Autor:
Cancer, Amy Moreno, Abhishek A. Solanki, Tianlin Xu, Ruitao Lin, Jatinder Palta, Emily Daugherty, David Hong, Julian Hong, Sophia C. Kamran, Evangelia Katsoulakis, Kristy Brock, Mary Feng, Clifton Fuller, Charles Mayo, BDSC Prostate Cancer BDSC Prostate
Publikováno v:
Cancers; Volume 15; Issue 12; Pages: 3121
Background: Clinical data collection related to prostate cancer (PCa) care is often unstructured or heterogeneous among providers, resulting in a high risk for ambiguity in its meaning when sharing or analyzing data. Ontologies, which are shareable f
Publikováno v:
Practical Radiation Oncology.
Autor:
Anjali L. Saripalli, Brian Lee, William Adams, Niranjan Bhandare, Bhanu P. Venkatesulu, Ryan K. Yoo, Jennifer Price, Grant A. Harmon, Alec M. Block, Nicholas Friedman, Matthew M. Harkenrider, Erica J. Major, William Small, Robert H. Wagner, James S. Welsh, Abhishek A. Solanki
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics.
Autor:
John Park, Bhanu Prasad Venkatesulu, Ksenija Kujundzic, Evangelia Katsoulakis, Abhishek A. Solanki, Lindsay L. Puckett, Rishabh Kapoor, Christina H. Chapman, Michael Hagan, Maria D. Kelly, Jatinder Palta, Jonathan B. Ashman, Dustin Jacqmin, Lisa A. Kachnic, Bruce D. Minsky, Jeffrey Olsen, Ann C. Raldow, Jennifer Y. Wo, Samantha Dawes, Emily Wilson, Randi Kudner, Prajnan Das
Publikováno v:
Practical Radiation Oncology. 12:424-436
Ensuring high quality, evidence-based radiation therapy for patients with cancer is of the upmost importance. To address this need, the Veterans Affairs (VA) Radiation Oncology Program partnered with the American Society for Radiation Oncology and es